The HEart iN Renal dIsease (HENRI) study V1.0
Research type
Research Study
Full title
Treatment decision-making in myocardial infarction for people with advanced kidney disease: A qualitative study.
IRAS ID
297507
Contact name
Jemima Scott
Contact email
Sponsor organisation
University of Bristol
Duration of Study in the UK
1 years, 6 months, 26 days
Research summary
Aims:
To understand how heart attack treatment decisions are made for, and by, people with kidney disease.
Background:
Kidney disease is common. In the UK kidney disease affects one in six people. People with kidney disease die, on average, at a younger age than those without kidney disease. Heart attacks are one of the most common causes of death in this population.
In the UK, one person suffers a heart attack every five minutes. Up to one in three will have kidney disease. There have been major advances in heart attack treatment over the past 50 years, and “gold-standard” (best practice) treatments now include a cocktail of medications as well as procedures to improve the blood supply to the heart. As a result of these advances, six out of seven people will now be alive one year after their heart attack. Only one in two people with kidney disease will however survive this long.
We do not know why people with kidney disease have such poor survival after heart attack. Previous research has shown that they are less likely to receive “gold standard” treatments for heart attack than those without kidney disease. We believe that if more people with kidney disease received these treatments, fewer people might die. It is important that we understand how and why treatment decisions are made for people with kidney disease, so we can learn how we can improve their heart attack care.
Methods:
We will interview clinical staff and people with kidney disease to understand their experiences and opinions about giving and receiving heart attack care. Participants will have a single one-on-one conversation with a researcher, in a place of their choosing.
This study is funded by the National Institute for Health Research. Participants will be recruited from between three and five hospital sites.
REC name
South West - Cornwall & Plymouth Research Ethics Committee
REC reference
21/SW/0162
Date of REC Opinion
8 Dec 2021
REC opinion
Further Information Favourable Opinion